- Home
- TBRG vs RNAC Comparison
TBRG vs RNAC Comparison
Compare TBRG & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBRG
- RNAC
- Stock Information
- Founded
- TBRG 1979
- RNAC 2007
- Country
- TBRG United States
- RNAC United States
- Employees
- TBRG N/A
- RNAC N/A
- Industry
- TBRG
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- TBRG
- RNAC Health Care
- Exchange
- TBRG NYSE
- RNAC Nasdaq
- Market Cap
- TBRG 351.8M
- RNAC 282.6M
- IPO Year
- TBRG N/A
- RNAC 2016
- Fundamental
- Price
- TBRG $22.06
- RNAC $13.32
- Analyst Decision
- TBRG Buy
- RNAC Strong Buy
- Analyst Count
- TBRG 3
- RNAC 5
- Target Price
- TBRG $23.67
- RNAC $40.00
- AVG Volume (30 Days)
- TBRG 215.3K
- RNAC 79.0K
- Earning Date
- TBRG 08-07-2025
- RNAC 08-07-2025
- Dividend Yield
- TBRG N/A
- RNAC N/A
- EPS Growth
- TBRG N/A
- RNAC N/A
- EPS
- TBRG N/A
- RNAC N/A
- Revenue
- TBRG $345,737,000.00
- RNAC $34,173,000.00
- Revenue This Year
- TBRG $5.15
- RNAC N/A
- Revenue Next Year
- TBRG $5.25
- RNAC N/A
- P/E Ratio
- TBRG N/A
- RNAC N/A
- Revenue Growth
- TBRG 3.56
- RNAC 31.91
- 52 Week Low
- TBRG $9.75
- RNAC $8.46
- 52 Week High
- TBRG $32.00
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- TBRG 36.87
- RNAC 65.93
- Support Level
- TBRG $22.34
- RNAC $10.71
- Resistance Level
- TBRG $24.05
- RNAC $15.57
- Average True Range (ATR)
- TBRG 0.91
- RNAC 1.02
- MACD
- TBRG -0.01
- RNAC 0.34
- Stochastic Oscillator
- TBRG 17.77
- RNAC 63.74
About TBRG TRUBRIDGE INC
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are Revenue Cycle Management (RCM), (ii) Electronic Health Records (EHR), and (iii) Patient Engagement The company derives maximum revenue from the RCM segment.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.